Momelotinib
id:
momelotinib-184-5727169
title:
Momelotinib
text:
Momelotinib, sold under the brand name Ojjaara among others, is an anticancer medication used for the treatment of myelofibrosis. It is a Janus kinase inhibitor and it is taken by mouth. The most common adverse reactions include dizziness, fatigue, bacterial infection, hemorrhage, thrombocytopenia, diarrhea, and nausea. Momelotinib was approved for medical use in the United States in September 2023, and in the European Union in January 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Momelotinib
date created:
2011-12-02T21:53:49Z
date modified:
2024-09-07T04:27:08Z
main entity:
{"identifier":"Q252602","url":"https://www.wikidata.org/entity/Q252602"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c9/Momelotinib.svg","width":512,"height":222}
fields total:
13
integrity:
16